The EULAR Congress awards a DocTIS study
The EULAR Congress, one of the most important gatherings in the field of rheumatology worldwide, couldn’t have started better for the DocTIS project.
The study, “DocTIS: A Single-Cell RNA-Seq Atlas of Drug Response to Targeted Therapies”, which will be presented by Dr. Antonio Julià, head of the Rheumatology Research Group at the Vall d’Hebron Institute of Research (VHIR) on Friday, June 13, has received the “EULAR 2025 Abstract Award” in the category of Basic and Translational Science. The prize was given during the Award Ceremony that took place onsite at the EULAR 2025 Opening Plenary Session on Wednesday, 11 June 2025. This recognition marks a significant milestone for the DocTIS project.
According to Antonio Julià, “this award represents a very important endorsement of the work done for this study by the leading organisation bringing together doctors, patients, and research institutions in rheumatology in Europe. It is a recognition that the DocTIS project is on the right path to investigate effective and personalized treatments for patients with immune-mediated inflammatory diseases (IMIDs)”.
Don’t miss Dr. Julià’s presentation:
- Study: DocTIS: A Single-Cell RNA-Seq Atlas of Drug Response to Targeted Therapies
- Date: Friday, June 13
- Time: 10:45 AM
- Location: FIRA Barcelona – Room B1
More information about the EULAR Congress here: https://congress.eular.org/
